National Trends of Antiparkinsonism Treatment in Taiwan: 2004–2011

Figure 1

Time trends for antiparkinsonism monotherapy prescription patterns from 2004 to 2011 for the total population (a) stratified by age <60 years (b) or ≥60 years (c). LD: levodopa; DA: dopamine agonist.

(a)

(b)

(c)